Prioritizing Disease Candidate Proteins in Cardiomyopathy-Specific Protein-Protein Interaction Networks Based on "Guilt by Association" Analysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Li, Wan ^a   Chen, Lina ^a   He, Weiming ^b   Li, Weiguo ^a   Qu, Xiaoli ^a   Liang, Binhua ^c   Gao, Qianping ^d   Feng, Chenchen ^a   Jia, Xu ^a   Lv, Yana ^a   Zhang, Siya ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; HEART RIGHT VENTRICLE DYSPLASIA; HYPERTROPHIC CARDIOMYOPATHY; NUCLEOTIDE SEQUENCE; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION;

ALGORITHMS; CARDIOMYOPATHIES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEINS;

EID: 84881183501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071191     Document Type: Article

References (82)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, et al. (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270-276.
2. Maron BJ, (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287: 1308-1320.
3. Lahtinen AM, Lehtonen E, Marjamaa A, Kaartinen M, Helio T, et al. (2011) Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 8: 1214-1221.
4. Mahon NG, Murphy RT, MacRae CA, Caforio AL, Elliott PM, et al. (2005) Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 143: 108-115.
5. Sen-Chowdhry S, Syrris P, McKenna WJ, (2010) Genetics of restrictive cardiomyopathy. Heart Fail Clin 6: 179-186.
6. Hughes SE, McKenna WJ, (2005) New insights into the pathology of inherited cardiomyopathy. Heart 91: 257-264.
7. Paul M, Zumhagen S, Stallmeyer B, Koopmann M, Spieker T, et al. (2009) Genes causing inherited forms of cardiomyopathies. A current compendium. Herz 34: 98-109.
8. Haugaa KH, Leren TP, Amlie JP (2009) Genetic testing in specific cardiomyopathies. F1000 Med Rep 1.
9. Carll AP, Haykal-Coates N, Winsett DW, Hazari MS, Nyska A, et al. (2011) Dietary salt exacerbates isoproterenol-induced cardiomyopathy in rats. Toxicol Pathol 39: 925-937.
10. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S, (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz 30: 535-544.
11. Glazier AM, Nadeau JH, Aitman TJ, (2002) Finding genes that underlie complex traits. Science 298: 2345-2349.
12. Piro RM, Di Cunto F, (2012) Computational approaches to disease-gene prediction: rationale, classification and successes. FEBS J 279: 678-696.
13. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL, (2002) Hierarchical organization of modularity in metabolic networks. Science 297: 1551-1555.
14. Lee TI, Rinaldi NJ, Robert F, Odom DT, Bar-Joseph Z, et al. (2002) Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298: 799-804.
15. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, et al. (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430: 88-93.
16. Ewing RM, Chu P, Elisma F, Li H, Taylor P, et al. (2007) Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3: 89.
17. Furney SJ, Calvo B, Larranaga P, Lozano JA, Lopez-Bigas N, (2008) Prioritization of candidate cancer genes-an aid to oncogenomic studies. Nucleic Acids Res 36: e115.
18. Wu X, Jiang R, Zhang MQ, Li S, (2008) Network-based global inference of human disease genes. Mol Syst Biol 4: 189.
19. Tranchevent LC, Barriot R, Yu S, Van Vooren S, Van Loo P, et al. (2008) ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Res 36: W377-384.
20. Kohler S, Bauer S, Horn D, Robinson PN, (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82: 949-958.
21. Chen J, Aronow BJ, Jegga AG, (2009) Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics 10: 73.
22. Linghu B, Snitkin ES, Hu Z, Xia Y, Delisi C, (2009) Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biol 10: R91.
23. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-311.
24. Nitsch D, Tranchevent LC, Thienpont B, Thorrez L, Van Esch H, et al. (2009) Network analysis of differential expression for the identification of disease-causing genes. PLoS One 4: e5526.
25. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R, (2010) Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol 6: e1000641.
26. Gefen A, Cohen R, Birk OS, (2010) Syndrome to gene (S2G): in-silico identification of candidate genes for human diseases. Hum Mutat 31: 229-236.
27. Li Y, Patra JC, (2010) Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network. Bioinformatics 26: 1219-1224.
28. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM, (2011) Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res 21: 1109-1121.
29. Oti M, Brunner HG, (2007) The modular nature of genetic diseases. Clin Genet 71: 1-11.
30. Feldman I, Rzhetsky A, Vitkup D, (2008) Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A 105: 4323-4328.
31. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci U S A 104: 8685-8690.
32. Chen JY, Shen C, Sivachenko AY (2006) Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac Symp Biocomput: 367-378.
33. Erten S, Bebek G, Ewing RM, Koyuturk M, (2011) DADA: Degree-Aware Algorithms for Network-Based Disease Gene Prioritization. BioData Min 4: 19.
34. Wang L, Tu Z, Sun F, (2009) A network-based integrative approach to prioritize reliable hits from multiple genome-wide RNAi screens in Drosophila. BMC Genomics 10: 220.
35. Oliver S, (2000) Guilt-by-association goes global. Nature 403: 601-603.
36. McKusick VA, (2007) Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet 80: 588-604.
37. Snel B, Lehmann G, Bork P, Huynen MA, (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28: 3442-3444.
38. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
39. Seal RL, Gordon SM, Lush MJ, Wright MW, Bruford EA, (2011) genenames.org: the HGNC resources in 2011. Nucleic Acids Res 39: D514-519.
40. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, et al. (2005) STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res 33: D433-437.
41. Frohlich H, Speer N, Poustka A, Beissbarth T, (2007) GOSim-an R-package for computation of information theoretic GO similarities between terms and gene products. BMC Bioinformatics 8: 166.
42. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
43. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
44. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, et al. (2006) Gene prioritization through genomic data fusion. Nat Biotechnol 24: 537-544.
45. Zhao HP, Lu D, Zhang W, Zhang L, Wang SM, et al. (2010) Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice. Acta Pharmacol Sin 31: 281-288.
46. Chu X, Thompson D, Yee LJ, Sung LA, (2000) Genomic organization of mouse and human erythrocyte tropomodulin genes encoding the pointed end capping protein for the actin filaments. Gene 256: 271-281.
47. Gazzerro E, Bonetto A, Minetti C, (2011) Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Handb Clin Neurol 101: 135-142.
48. Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, et al. (2008) Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 88: 275-283.
49. Teixeira PC, Santos RH, Fiorelli AI, Bilate AM, Benvenuti LA, et al. (2011) Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy. PLoS Negl Trop Dis 5: e1205.
50. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, et al. (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31: 94-99.
51. Jin B, Luo XP, Ni HC, Shen W, Shi HM, et al. (2012) A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Mol Biol Rep 39: 221-226.
52. Jin B, Ni H, Geshang Q, Li Y, Shen W, et al. (2011) HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: a meta-analysis involving 11,761 subjects. Tissue Antigens 77: 107-111.
53. Rosales XQ, Moser SJ, Tran T, McCarthy B, Dunn N, et al. (2011) Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I. J Cardiovasc Magn Reson 13: 39.
54. Alcalai R, Seidman JG, Seidman CE, (2008) Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19: 104-110.
55. Bos JM, Towbin JA, Ackerman MJ, (2009) Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 54: 201-211.
56. Delmar M, Makita N, (2012) Cardiac connexins, mutations and arrhythmias. Curr Opin Cardiol 27: 236-241.
57. Clarke NF, Domazetovska A, Waddell L, Kornberg A, McLean C, et al. (2009) Cap disease due to mutation of the beta-tropomyosin gene (TPM2). Neuromuscul Disord 19: 348-351.
58. Kato H, Takashima S, Asano Y, Shintani Y, Yamazaki S, et al. (2008) Identification of p32 as a novel substrate for ATM in heart. Biochem Biophys Res Commun 366: 885-891.
59. Lefeber DJ, de Brouwer AP, Morava E, Riemersma M, Schuurs-Hoeijmakers JH, et al. (2011) Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet 7: e1002427.
60. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, et al. (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5: 320-326.
61. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA, (1997) Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 95: 2434-2440.
62. Dellefave L, McNally EM, (2010) The genetics of dilated cardiomyopathy. Curr Opin Cardiol 25: 198-204.
63. Chu M, Iyengar R, Koshman YE, Kim T, Russell B, et al. (2011) Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy. Cardiovasc Res 92: 409-419.
64. Chen C, Jamaluddin MS, Yan S, Sheikh-Hamad D, Yao Q, (2008) Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 28: 906-912.
65. Hammer E, Goritzka M, Ameling S, Darm K, Steil L, et al. (2011) Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies. J Proteome Res 10: 2161-2171.
66. Teraguchi M, Ohkohchi H, Ikemoto Y, Higashino H, Kobayashi Y, (2003) CD36 deficiency and absent myocardial iodine-123-(R,S)-15-(p-iodophenyl)-3-methylpentadecanoic acid uptake in a girl with cardiomyopathy. Eur J Pediatr 162: 264-266.
67. Cernuda-Morollon E, Ridley AJ, (2006) Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 98: 757-767.
68. Pankuweit S, Ruppert V, Maisch B, (2004) Inflammation in dilated cardiomyopathy. Herz 29: 788-793.
69. Mearini G, Gedicke C, Schlossarek S, Witt CC, Kramer E, et al. (2010) Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc Res 85: 357-366.
70. Kang MY, Zhang Y, Matkovich SJ, Diwan A, Chishti AH, et al. (2010) Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. Circ Res 107: 903-912.
71. Ren J, Avery J, Zhao H, Schneider JG, Ross FP, et al. (2007) Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol 42: 367-377.
72. Masuelli L, Bei R, Sacchetti P, Scappaticci I, Francalanci P, et al. (2003) Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts. Cardiovasc Res 60: 376-387.
73. Nakajima H, Yanase N, Oshima K, Sasame A, Hara T, et al. (2003) Enhanced expression of the apoptosis inducing ligand TRAIL in mononuclear cells after myocardial infarction. Jpn Heart J 44: 833-844.
74. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, et al. (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366: 619-628.
75. Janssen PM, (2010) Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere. Am J Physiol Heart Circ Physiol 299: H1092-1099.
76. Krishnamurthy P, Subramanian V, Singh M, Singh K, (2007) Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension 49: 865-872.
77. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38: W214-220.
78. Hotarkova S, Hermanova M, Povysilova V, Dvorak K, Feit J, et al. (2004) Demonstration of MyoD1 expression in oncocytic cardiomyopathy: report of two cases and review of the literature. Pathol Res Pract 200: 59-65.
79. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, et al. (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352: 362-372.
80. Lin AE, Alexander ME, Colan SD, Kerr B, Rauen KA, et al. (2011) Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome. Am J Med Genet A 155A: 486-507.
81. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, et al. (2004) Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386.
82. Marmolino D, (2011) Friedreich's ataxia: past, present and future. Brain Res Rev 67: 311-330.